"Weight Loss Without Side Effects" New Anti-Obesity Drug Candidate Found in Pythons
Pythons May Selectively Suppress Appetite
Many Reptiles Lack Genes That Stimulate Appetite
There is growing attention to the prospect that the secret behind pythons' ability to survive without food for several months to nearly a year could provide clues for the development of new anti-obesity drugs.
A joint research team from Stanford University, the University of Colorado Boulder, and Baylor College of Medicine in the United States announced that they have discovered a metabolic compound in python blood that suppresses appetite. The research findings were recently released in the international journal Nature Metabolism.
The study focused on the Burmese python, which is known to be capable of fasting for several months or even more than a year after swallowing prey equal to its own body weight in one meal. Immediately after eating, the heart enlarges by about 25%, and the metabolic rate surges by up to 4,000 times, resulting in extreme physiological changes.
The researchers compared blood samples from pythons before and after feeding them a large meal following a 28-day fast. As a result, more than 200 types of metabolic compounds increased within several hours after eating, among which 'para-tyramine-O-sulfate (pTOS)' surged by up to over 1,000 times. This compound is produced by gut microbes and has been found to exist in small amounts within the human body as well.
Animal experiments revealed that pTOS selectively suppressed appetite without affecting energy expenditure or organ size. When administered to obese mice, their food intake decreased and their body weight dropped by about 9% within four weeks.
The research team explained that this compound works differently from existing anti-obesity drugs. Currently, widely used GLP-1 drugs suppress appetite by slowing gastric emptying, whereas pTOS is analyzed to act directly on the hypothalamus in the brain to regulate appetite. This suggests that it may also reduce side effects such as nausea or abdominal pain.
The secret of pythons, which can survive starving for several months to nearly a year, is expected to provide clues for the development of new drugs to treat obesity. Pixabay
View original imageProfessor Leslie Leinwand, who led the research, said, "We have discovered a new candidate compound that can suppress appetite without the side effects of existing drugs," adding, "Since this substance also exists in the human body, there are expectations regarding its safety." However, she emphasized that further research and clinical validation are required before it can be developed into an actual therapeutic drug.
Meanwhile, in February, a research team from the University of Porto in Portugal announced that snakes either completely lack the gene responsible for producing the appetite-stimulating hormone ghrelin, or the gene is nonfunctional. The results were published in the international journal Royal Society Open Biology.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Ghrelin is a hormone found throughout vertebrates, including humans, and plays a key role in inducing hunger, regulating digestion, and controlling fat storage. However, in snakes and other reptiles with long intervals between meals, such as chameleons, the ghrelin gene has either disappeared or become severely damaged. This change is known to be common among species that have adapted to frequent fasting.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.